Skip to main content

Christopher A. Simon

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher A. Simon

Christopher A. Simon is recorded as CEO and Board Member at Haemonetics Corp (HAE). The proxy statement of Haemonetics Corp reports total compensation of $12,044,701 for Christopher A. Simon in fiscal 2026, including a base salary of $1,100,008. Disclosed compensation is on record for 9 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Haemonetics Corp

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Haemonetics Corp (HAE) $1,100,008 $12,044,701
2025 Haemonetics Corp (HAE) $1,100,000 $10,722,488
2024 Haemonetics Corp (HAE) $1,088,469 $11,545,113
2023 Haemonetics Corp (HAE) $1,012,885 $10,686,395
2022 Haemonetics Corp (HAE) $945,000 $8,702,220
2021 Haemonetics Corp (HAE) $963,173 $8,625,394
2020 Haemonetics Corp (HAE) $937,211 $9,398,204
2019 Haemonetics Corp (HAE) $893,954 $8,550,810
2018 Haemonetics Corp (HAE) $858,462 $7,851,310

Recent activity

No call appearances or filed executive changes recorded yet.